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Objectives. This study attempted to determine the sensitivity 
and specificity of coronary Row reserve derived using transesoph- 
ageal echocardiography for left anterior descending coronary 
artery stenosis. 
Background. Transesophageal echocardiography can be used to 
measure coronary flow velocity and may provide a less invasive 
means of assessing coronary flow reserve. 
Metlrodr. Seventy-eight adult patients were studied by pulsed 
Doppler transesophageal echclrardiography of dhe proximal left 
anterior descending coronary artery during a control period and 
peak (i.c., 40 &kg body weight per min) dobutamine infusion. 
Coronary flow reserve index was calculated as the ratio of 
maximal dLstolir. coronary velocity at peak dobutamine infusion 
tcg [he control level and was considered abnormal if ~1.81. 
‘Two-dimensional transesophageal eft ventricular views were ob- 
tained for analysis of wall motion. 
RE;ulls Coronary angiography showed 270% (group A, n = 
IS), Al% to <70% (group B, n = 21) and no (group C, n = 39) left 
anterior descending coronary artery diameter stenosis. An abnor- 
Coronary angiography is commonly used to assess the hemo- 
dynamic significance and severity of coronary artery disease. 
However, coronary anatomy may not reflect the functional 
significance of coronary stenosis (1:2). Assessing coronary flow 
reserve may be a more sensitive method of detecting hemody- 
namicaiiy significant coronary artery stenosis (1,3). However, 
in\ asive methods ‘ire typically needed to assess coronary flow 
reserve and limit the clinical application of coronary flow 
reserve in the assessment of coronary artery disease (3,4). 
Positron emission tomography has been used to measure 
myocardial perfusion reserve (5). Although this method is 
noninvasive, it is expensive and not widely avaiiabll:. Trans- 
esophageal echocardi?giaphy allows for high resohition im- 
ages of the proximal coronary arteries, and pulsed Doppler can 
be performed to obtain left anterior descending coronary 
velocity (6,7). Limited data exist 011 the application of Doppler 
transesophageai echocardiography for the assessment of cog 
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mal coronary flow reserve index did not differ from 3 ~tr regional 
wall motion abnormality in sensitivity for IeB anterior descending 
coronary stenosis in group A (15 [83%] of I8 VW, IS (83%I of 18, 
p = NS) but was significantly more sensitive in group B (12 [570/o] 
of 21 vs. 2 [IO%] of 21, p < 0.025). The opecificity for no left 
anterior descending coronary stenosis in group C between a 
normal coronary flow reserve index and no new rrgiornal wall 
motion abnormality did not differ (87% vs. 97%, p = NS). 
Conclusion. Doppler coronary flow reserve and two-dimensional 
d&tamine transesophageal echocardiography are equally sen& 
tive for the detection of lelt at*,terior descending coronary stenosis 
270% and equally specific. However, Doppler coronary flow 
resene, compared with two-dimensional dobutamine transesoph- 
ageal e&cardiography, is more sensitive for intermediate left 
anterior descending coronary stenosis and may play a significant 
adjunctive role to cardiac catheterization and other noainvasive 
techniques for assessing coronary artery disease. 
(J Am Coil Cardiul I995;25:325-32) 
onary blood flow reserve (8). It is unknown whether the measure- 
ment of coronary flow reserve by Doppler transesophageai echo- 
cardiography is more sensitive for the detection of coronary artery 
disease than the more conventional assessment of pharmacolog- 
ically provoked regional wall motion abnormalities as assessed by 
two-dimensional echocardiography (9-16). 
W: postulated that coronary Aow reserve as assessed by 
pulsed Doppler transesophageai echocardiography would be a 
more sensitive method of detecting left anterior descending 
coronary artery disease than analysis of left ventricular wall 
motion. The purposes of the study were to determine the 
feasibility of obtaining coronary flow measurements using 
pulsed Doppler transesophageai echocardiography during do- 
butamine infusion and the sensitivity and specificity of dobut- 
amine Doppler transesophageai echocardiography-derived coro- 
nary flow reserve measurements for ieft anterior descending 
co!-onary stenosis and to compare the Doppler transesophage. 
al echocardiographic technique wiih that of d;butamine two- 
dimensional echocardiography. 
Methods 
Patients. lilghty-nine patients (72 men, 17 women) meet- 
ing inclusion criteria were enrolled. Doppler transesophsgeal 
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Figure 1. Pulsed Doppler place- 
ment of sample volume (arrow) 
in the praimal left anterior de- 
scending coronary artery (LAD) 
during dobutamine transesopha- 
geal echocardiography (left panel) 
to measure left anterior descend- 
ing coronary artery systolic (S) and 
diastolic (D) coronary velocity 
@l&t panel). Dotted line and cir- 
de (right panel) represent Dopp 
ler sample volume alignment and 
placement, respectively. A0 := 
aorta; CM/S = centimeters per 
second; EKG = electrocardio- 
gram; LA = left atrium; M/S = 
meters per second. 
echocardiography of the proximal left anterior descending 
coronary artery was technically inadequate in eight patients, 
and three patients were excluded for the presence of aortic 
stenosis !.n = l), left main coronary artery stenosis (n = 1) and 
intracardiac thrombus (n = 1). Thus, 78 patients (66 men, 12 
women, mean [“-SD] age 62 I 12 years, range 20 to 85) 
comprised the study group. Inclusion criteria included coro- 
nary angiogaaphy within 1 month of transesophageal echocar- 
diograFhy, no contraindication :o transesophageal echocardi- 
ography, technically inadequate two-dimensional transthoracic 
echocardiography and norma! sinus rhythm. Patients with 
unstable angina, recent myocardial infarction (i.e., <6 weeks), 
decompensated congestive heart failure, complex ventricular 
ectopy or previous coronary bypass graft surgery were not 
enrolled. Antianginal medicati Jns were disc--tint& a mini- 
mum of 12 h before dobutamine transesophageal echocardi- 
ography. iu’o patient was receiving a long-acting beta-adrenergic 
blocking agent or calcium antagcnis!. idI patients gave written 
informed consent. The study was approved by the Hurrqr, Studies 
Committee at our institution. 
Dobutamine transesophrgeal echocardiography. Dobut- 
amine transesophageal echocardiography was performed with 
the patient in the supine or left lateral decubitus position. 
‘r- ’ . +La I oropharyngcal anesthetic spray and intrrlenous t’IIlUd- 
zolam for sedation were useJ before introducrng the trans- 
esophageal scope. Echocardiographic studies were performed 
with a Hewlett-Packard Sonos 1500 echocardiographic ma- 
chine using a 5 O-MHz 64-element monoplane (n = 15), 
4S-element biplane (n = 53) or 64-elelnent omniplane (n = 
13) transesophagcal scope. 
Dobtitamine was intravenously infused in 3-min stages at 
increasing doses from 5.0 to 40.0 pfl.g body weight per min. 
Dobutamine infusion was discontinued for development of a 
regional left ventricular wall motion abnormality, complex 
ventricular ectopic beats, heart rate >85% of the estimated 
peak maximal heart rate (i.e., 220 - age in years) for >2 min, 
systemic hypertension (i.e., systolic blood pressure >200 mm Hg) 
or systemic hypotension (i.e., systolic blood pressure 
~90 mm Hg). Heart rate, pulse oximetry and three-lead 
electrocardiogram (ECG) were continuously monitored 
throughout the procedure. A IZlead ECG was obtained and 
blood pressure measured in the control period, every 2 min 
into each stage, at peak and every minute for 10 min into 
recovery. Two liters of oxygen per nasal cannula was routinely 
used. 
Pulstd Doppler transesophageal echocrdiography was 
performed in the immediate proximal segment of the left 
s;lterior descending coronary artery during the control period 
and peak dobutamine infusion by- placement of the sample 
volume during diastole from a horizontal basilar short-axis 
view (Fig. 1). The method of identifying the proximal left 
an-erior descending artery for placement of the Doppler 
sample volume was as follows: 1) a short-axis view at aortic 
vain.; level was obtained using mauima! leftwald flexion of the 
horizontal plane or best multiplane axis; 2) color flow Doppler 
was activated, and the scope anteflexed or slightly withdrawn, 
or both. to visualize the left Mann ostium; 3) ‘slight rightward 
flexloq or rotation of the plant: was used ‘o identify the 
bifurcation of the left main coronary arteli/ Z”IJ TV minimize 
ihe angle of incid:ncc; 4) the sample volume was placed in the 
proximal left anterior descending artery immediately distal to 
.lr ltft main corollary artery; S) the view obtained at control 
was reproduced during peak dobutamim: inftision. 
When a monoplane scope was used, two-d; mensional views 
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obtained at control, low dose (i.e., 5.0 pgkg per min) and peak 
dobutamine dose included the four-chamber, five-chamber 
and short-axis views of the left ventricle from the base to the 
apex. During intermediate stages, short-axis left ventricular 
views were obtained. When a biplane or omniplane scope was 
used, views obtained at the control period, low dose and peak 
dnbutamiae dose included four-chamber, two-chamber and 
short-axis views from the base to the apex and the transgastric 
long-axis view. Images during intermediate stages included 
either four- and two-chamber views or transgastric short-axis 
and long-axis views, depending on which provided the best 
image quality. In addition, views intermediate between the 
four- and two-chamber planes were obtained with the om- 
niplane scope. Echocardiographic images were recorded on 
videotape and on-line or off-line to floppy disk using a cine- 
loop display in a quad-screen format (Cineview, GTI Free- 
land). 
When the monoplane scope was used, echocardiographic 
views displayed in a qilad-screen format included the four- 
chamber, five-chamber and short-axis views at the base and 
papillary muscle levels. With use of the biplane or omniplane 
scope, the four-chamber, two-chamber and short-axis views at 
the base and papillary muscle levels were displayed in quad- 
screen foflfldt. M-mode transesophageal echocardiography of 
the left ventricle immediately below the mitral valve leaflet tips 
during the control period was performed as previously de- 
scribed (17). Coronary Doppler and M-mode echocardiogra- 
phy were recorded on hard copy at a sweep speed of 100 mm/s 
for subsequent review and analysis. 
Transesophageal echocardiographic analysis. Diastolic 
coronary velocity :vas determined using a digitizing pad inter- 
faced with a commercially available computer and customized 
software. The ratio of maxim&l diastolic coronary velocity at 
peak dobutamine to control was calculated as an index of 
coronary flow reserve. A coronary flow reserve index cl.81 
(i.e., >1 SD below the mean coronary flow reserve in&x of the 
normal group) was the criterion for abnormal hemodynamic 
function, and a normal coronary flow reserve index was 
considered ?l.Si. Left ventricular wall motion derived using 
two-dimensional transesophageal echocardiography was oual- 
itat+ely assessed to be hyy -rdynamic, normokinetic, hypoki- 
@ir- &netic or dyskinetic. A two-dimension&l transesupha- 
geal echocardiographic test indicative of left anterior 
descending coronary artery stenosis was the development of 
hypokinesia, akinesia or dys::i;~L. of a previously contractile 
left ventricular segment in the distr hution of the left ventric- 
ular Apex, anterior wall or septum. Left ventricular diameter 
and anterior and irJerior wall thicknesses were measured at 
end-diastoie (i.e., anset of QRS complex) with electronic 
calipers using a leading-edge to leading-edge technique. Left 
ventricular mass wds caicuiateu using the modified formula of 
Devereux et al. (18) Left ventricular +ypertrophy was defined 
a? !eft vcntricuiar mdss divided by hod;: surface area >llO g/m2 
far women and >134 s/m2 for meu T:.ree to five derermina 
tions of coronary velocity mcascrzments were made and 
averaged. M-mode measurements ~,vere made in triplicate and 
averaged. M-mode, two-dimensional and Doppler transescyh 
ageal echocardiography were assessed in a bhnded manner. 
Coronary angiography. Selected percutaneous coronary 
angiography was performed from multiple projections and 
recorded on tine iiim. A stenosis was assessed using orthogo- 
nal projections. Lumcrl diameter stenosis was determined by 
an experienced investigator unaware of the echocardiographic 
data. 
Statistical analysis. Results are mean value ir t SD or 
proportions of the study popuiation. Analysis of variance 
(Scheffe F test) was used to assess differences in variables 
amon groups. A paired Student t test was used to assess 
differences in vartabies from control period to peak dobut- 
amine dose within a group. The McNemar test statistic was 
used to assess differences in sensitivity and specificity of 
Doppler compared with two-dimensional transesophageal 
tchocardiography. Chi-square a,nalysis was used to assess 
differences in proportions among groups. Multiple stepwise 
linear regression analysis with dummy vai,iabies for the pres- 
ence (I) or absence (0) of a discrete variable and least-squares 
linear regression ana?ysis were performed to assess determi- 
nants of coronary flow reserve index (StatviewdlZ+, Brain- 
Power, Inc.). The intraobscrycr and interobserver variability 
was calculate? as the absolute difference in a variable mea- 
sured at two times divided by the mean value of the two 
measurements times 100%. Intraobserver variabili!y nxssure- 
ments were made at least 1 month apart. A Bonferroni 
correction for multiple pairwise comparisons yielding a two- 
tailed p value <0.0!25 (i.e., O.OV4) was considered statistically 
s:;mticant for the Student t test (19). A p value co.05 was 
considered statistically significant for sll other analysts. 
Results 
Feasibility and safety ofdobutamine transesophageal echo- 
cardiography. Dobutamine transesophageal echocardiogra- 
phy was feasible in 78 (86%) of 89 patients. The test *~a: 
generally well tolerated. No complications were experienced. 
Coronary angiography. Patients were prospectively classi- 
fip4 into one of three groups on the basis of left anterior 
descenciirlg altery stenosis severity: 18 pzticnts hact 2 proximal 
or m&left anterior descending coronary artery ‘:lmen dial.,- 
eter stenosis ~76% (group A); 21 had proximal or mi&left 
anterior descending coronary artery lumen diams,lr stenosis 
from >O% to ~70% (group B); and 39 had no lelt anterior 
descending coronary artery stenosis (group C). in group B, left 
anterior descending coronary stenosis ranged tram 1SL;i to 
60% (mean 44 -+ 11%). In group B, 11 patients (group Bl) had 
left anterior descending coronary stenosis <50% (mean 35 + 
R%, range 15 to n3%), and 10 (group B2) had st.znosis ~50% 
(midn 53 ? 5%, range 50 to 60%). Circumflex or right, or 
both, coronary artery diameter stenosis ~50% was significantly 
more frequent in group A (15 [83%] of 18) tha*: rn group B (5 
[24%] of ‘21, p < 0.001) or group C (8 [21%] of39, p < C.001). 
One (9%) cf 11 and 4 (4’3%) of 10 patients had circumflex or 
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Table I. Coronary Flow Reserve in 73 Patierts With and Without 
Left Anterior Descending Coronary Artery Stenosis 
Maximal Diastolic 
Coronary Velocity 
Control Peak 
Study No. of State Dobutamine 
Group Pts (cm/s) Dose (cm/s) CFR Index 
h 
(~70% LAD stenosis) IX 44~22 60+22*'F 1.52?0.65t 
B 
(>O% to <70% LAD stenosis) 21 13 i 13 78 i 27t$ 1.93 t 0.87t 
c 
(no LAD stenosis) 39 402 10 99533” 2.51 -c 0.70 
*p = 0.0001, $p < 0.002 versus control state. ?p = 0.0001 versus group C 
(Scheff6 F test). Data presented are mean value 2 SD. CFR = coronary flow 
reserve; LAD = left anterior descending coronary artery; Pts = patients. 
right, or both, coronary artery stenosis ~50% in groups Bl and 
B2, respectively. 
Coronary flow reserve. The maximal diastolic coronary 
ve!.ocity during the control period did not differ among groups 
A, B and C. Maximal diastolic coror.ary velocity increased 
from control to peak dobutamine infusion in all groups (Table 
1). However, the magnitude of the increase in diastolic coro- 
nary velocity was greater for group C than for group A or 
group B, as reflected by coronary flow reserve index (Table 1, 
Fig. 2). In group Bl versus B2, no differences were found 
between maximal diastolic coronary velocity in the control 
period (44 -C 12 vs. 42 or. 14 cm/s, p = NS) and peak 
dobutamine dose (72 ? 16 vs. 84 t 35 cm/s, p = NS) or in 
coronary flow reserve index (1.70 t 0.35 vs. 2.19 f 1.18, p = 
NS). Maximal diastolic coronary velocity during peak dobut- 
amine in group C was significantly greater than that in group A 
(p = 0.0001) or group B (p = UlOOi) (Table 1). Case examy!<s 
of abnormal and normal coronary ho+4 reserve are shown in 
Figures 3 and 4. 
Coronary flow reserve versus wall moth analysis. The 
sensitivity of an abnormal coronary flnw reserve index (i.e., 
~1.81) versus a new wall motion abnormalit;, in the left 
anterior descending coronary distrl’oution for detection of 
~70% diameter stenosis of the left anterior deacend:ng COT;). 
nary artery in group A was comparable (15 [83%] of 18 vs. 15 
[83%] of 18, p =T NS). The sensitivity of either an abnormal 
coronary flow reserve index or a uew wall motion abnormahty 
in the lett anterior descending coronary disrributton during 
dobutamine aransesl .?hageal echocardiograohy for the dctec- 
lion of a ~70% left anterior descending stenosis in group A 
was I Wl% (18 of t t;). An abnormal coronar;i flow reserve ii&x 
was more sensitive than a new wall motion abnormality in the 
distribution of the left an!eriot descend:qg coronary artery 
during transesophagsal echoczrcrography fcr the detection of 
>O% to ~70% diameter stenosis; of the left amerior descend- 
ing coronary artery in group B f 12 [57%] of 21 vs. 2 [lo%] of 
21, p < O.D25j. An abnormal coronary Row reserve index was 
present in 7 (64%) of 11 patierlts of group Bl and in j (50%) 
0 
0 
0 
0 
880 
: 
8Zo. 
0 
GROW C GROUP B GROUP A 
Figure 2. Coronary flow reserve indexes for group A (left anterior 
descending coronary artery stenosis r70%), group B (left anterior 
descending coronary ariery stenosis >O% to ~70%) and group C (no 
left anterior descending coronary artery stenosis). Coronaty flow 
reserve index was calculated as the ratio of peak dobutamine to control 
maximal diastolic coronary velocity. Solid circles and squares repre- 
sent no new wall motion abnormality during dobutamine transesoph- 
ageal echocardiography. Open circles snrl squares represent new wall 
motion ?hoormality. In group B, circles represent sti>jects with ~50% 
and squares those with -685 left anterior descending corcnary artery 
stenosis, respectively. 
of 10 patiems in grorup B2. A new wall motion abnormality in 
the left anterior descending coronary distribution was present 
in 0 (0%) of 11 pazients of group Bl and in 2 (20%) of 10 
patients of group B2. A normal coronary flow reserve index 
(i.e., 21.81) and no provoked wall motion abnormality in the 
let anterior descending coronary distribution during dobut- 
i mine transesophageal echocardiography were equally specific 
1or nti stenosis of the left anterior descending coronary artery 
in group C (34 ]87%] of 39 vs. 38 [97%] of 35, p = NS). 
Myocnrdial infarction in the distribution of the left anterior 
descending coronary artery was more common in group A (5 
[28%jj of 18) than in group B (1[5%] of 21, p < 0.05) or group 
C (0 ]O%] of 39, F < 0.005). Coronary flow reserve index of 
patients in group A with (n == 5) verse 1 those without (n = 13) 
a previous anterior myocardial infarc&n did not differ (1.73 +- 
0.30 vs. 1.44 t 0.74, p = NS). Myocardial ischemia (i.e., new 
wall motion abnormality) remote to the left anterior descend- 
ing coronary distribution during peak dobutamine dose was 
more common in group A (8 [44%] of 18j than in group B (3 
[14%] of 21, p < 0.05) or group C (5 [13%] of 39, p < 0.01). 
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Figure 3. Case example of de- 
creased left anterior descend- 
ing coronary artery flow reserve 
(arrows) in a patient with prox- 
imal left anterior descending 
coronary stenosis 270%. Le& 
panel, Control state. Right 
panel, During peak dobut- 
amine infusion. Abbreviations 
as in Figure 1. 
Influesce of dnbutamine on hemudynamic variables. Do- 
butamine was infused to a maximal dose (i.e., 40 &kg per 
min) in all patients with the exception of three because of the 
development of new wall motion abnormality in two in group 
A and systolic hypertension in one in group B. Heart rate and 
systolic and diastolic blood pressures daring the control period 
or peak dobutamine dose did not differ among groups A, B or 
C (Table 2). Heart rate significantly incl. r,sed from the control 
period to peak dobutamine dose in all &“:oups. The percent of 
the age-predicted maximal heart rate w hieved did not differ 
Figure 4. Case example of 
normal left anteric . descend- 
ing ~~1~4,dry artery Row re- 
serve (arrow) in a patient with 
no left anterior descending 
coronxy stenosis. Left pm@I, 
Control state. Right panel, 
During peak dobutamine infu- 
sion. Abbreviations as in Fig- 
zre 1. 
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Tabie 2. InHuence of Dobutamitv on Hcmodynamic Variables 
_.--__ - -- -_ 
Contrcll State Zak D3hutaminc Dose 
-II -- 
No. of HR SPB DBP HR SUP DBP 
iirq Pts (he;:clmin) imm Hg) (mm HP) (brilrimin) (mm Hg) (mm tlg) 
--~ -- .____ 
A 18 89-c 19 14s t 23 86-c 12 138 2 14’ I40 It 40 7lz 17 
B ?I 822 14 149 + 25 xi1 i- I? 12x 2 23” 14h f 31 71 z 13t 
i’ 3’) 85 2 14 14R 2 30 x1 i 14 !36 5 ?I* Ihl i 3h 80 z 27 
*p = 0.0001, tp < 0.00~~5 vrws control state (Bonferroni). Heart rate (HR) and diastolic (EBP) and systolic (SBP) Mood preswc during control state or 
dohutamine did nof differ znong groups A, B or C (SchetT6 F test). Data presented are mean value + SD. Other abhreviativnr as in lahle 1. 
(p 2: NS) among groups A (88 f iO%), B (85 I- 15%) and C 
(88 I! 14%). The percent of patients achieving a peak heart 
rate of at least 85% of the age-predicted maximum did not 
differ (p = NS) among groups A (16 [69%] of 18), i3 (18 [86%] 
af 21) and C (34 [87%] of 39). In group A, two patients 
developed a new ;vall motion abnormality befoit: achieving 2 
heart rate of 85% of the age-predicted maximum. Both 
subjects had an abnormal coronary flow reserve index. Three 
patients in group B had suboptimal peaK heart rate (i.e., ~85% 
of age-predicted maximum) because of a bhmted heart rate 
response (n = 2) or discontinuation of dobutamine for pro- 
voked sys:nlic hypertension (n = 1). Coronary flow reserve was 
abnormal in two of the three patients, but no new wall motion 
abnormality was seerI. In group C, five subjects had 2 subop- 
ti!ual peak heart rate because of a blunted heart rate response. 
Four of the five patients had a normal coronary flop reserve 
index. No new wail motion abnormality was provoked in any of 
the five patients. 
Left vemltricular mass. Left ventricular mass did not differ 
(p = NS) among groups A (22Y f 53 g), B (248 t 119 g) or C 
(242 i 101 g). Left ventricular mass corrected for body surface 
area did not differ (p = NS) among groups A ‘i ij ? 22 g/m’), 
B (123 C 52 g/m’) or C (125 -+ 58 g/m’). The frequency of 
patients with left ventricular hppertrophy did not differ (p =c 
NS) among groups A (3 [17%] of 18), B (7 [33%] of 21) or C 
(12 [31%] of 39). 
Coronary How reserve: regression analysis. Muitivariate 
regression analysis demonstrated the percent diameter stenosis 
of the left anterior descending coronary artery as the only 
independent predictor of coronary flow reserve index (r = 
-0.47, p = 0.0001). Variables that were not independent 
predictors inciuded left ventricclar mass, ischemia remote to 
the left anterior descending coronary distribution, myocardial 
infarction in the left anterior descending coron;.ry distribution, 
percent or absolute change in heart rate, systolic and diastolic 
blood pressures and anterior wall thickne:;. Least-squares 
linear regression analysis showed d weak but significant corre- 
lation bebeen coronary tfow reserve index and percent diam- 
eter stenosis of the left anterior descending coronary artery 
(r = -0.47, p = 0.0001). 
Intraobservar and interobserver variability. Observer vari- 
ability was determined in 20 patients of the study group 
selected at random. The percent and absolute intraobserver 
variabi!ity were. respectively, 6.2 t 7.9% and 3 -t 4 cm/s for 
maximal coronary velocity at control, 4 7 F 4.8% and 4 ? 
5 cm/s for maximal coronary velocity at peak and 7.5 -+ 6.1% 
and 0.18 f 0.18 for coronary Row reserve index. Tbe percent 
and absolute interobserver variability were, respectively, 6.7 -+ 
9.7% and 3 2 5 cm/s for maximal coronary velocity at control, 
4.8 +- 5.2% and 5 2 7 cm/s for maximal coronary :zlocity at 
peak and 8.3 2 10.2% and 0.22 t 0.29 for coronary flow 
reserve index. 
Discussion 
In the present study, pulsed Doppler dobutamine trans- 
esophageal echocardiography was shown to be a feasible and 
safe method for the measurement of coronary flow reserve and 
detection of left anterior descending coronary artery stenosis. 
The sensitivity of coronary flow reserve assessed using dobut- 
amine transcsophageal echocardiography was comparable to 
W-dimcnsionai wall motion analysis for the detection of 
severe left anterior descending coronary stenosis. However, 
coronary flow reserve assessed using dobutamine Doppler 
tramesophageal echocardiography was more sensitive than 
provoked wall motion abnormalities for the detection of 
intermediate left anterior descending coronary stenosis. Dopp- 
ler and kwo-dimensional dobutamine transesophageal echocai- 
diography were equally specific fGi !he dotermination of no left 
anterior descending coronary stenosis. L’sing dobutamine !rans- 
esophageal echocardiograpby lo measure coronary Bow re- 
serve appears to add to the assessment of intermediate left 
anterior descending coronary stenosis and may allow wider 
clinical application of the coronary flow reserve technique. 
Coronary Aow reserve, Coronary sngiographic assessment 
of ccronary anatomy has significant limit?” in predicting 
the hemodynamic significance of a coronary artcry stenosis, 
which can be assessed by the capacity of the coronary vessel to 
augment blyud flow during conditions of increased myocardial 
oxygen demand. The concept of coronary flow reserve, which 
describes the capacity of the coronary circulation to augment 
blood flow maximally, has broadened the understanding of 
coronary artery disease in humans. Unfortunately, present 
methodologies applicable to assessing coronary flow reserve in 
humans are either invasive (3,4) or expensive (5) and hamper 
the widespread application of these techniques for this pur- 
pose. Accordingly, knowledge concerning regulation of coro- 
nary flow in humans is considerably less than that in animal 
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models (20). Although, strict!y speaking, transesophagcal 
echocardiography ic semi-invasive, it is far less invasive than 
cardiac catheterization. Also, it is 1,:s~ costly. and serial studies 
are more feasible. Doppler transcsophageal echocardiography 
shows promise for increasing kr::jwledge of coronary flow 
reserve in humans. 
In addition to the degree of epicardial coronary artery 
stenosis, factors that independently influence coronary flow 
reserve include left ventricrzlar hypertrophy (21), heart rate, 
coronary perfusion pressure and ventricular preload (22,23), 
contractility (24), recent myocardia! infarction, &hernia at a 
distance (24) and mCeasurement echnique (20,25,26). These 
additional faclc..,s may lessen the clinical utility of coronary 
flow reserve measurements in individual patients when at- 
tempting to assess hemodynamic significance of coronary 
stenosis. Transesophageal echocardiography is potentially ad- 
vantageous as a technique to measure coronary flow reserve 
becarlse it circumvents the need to instrument the coronary 
artery directly, as is the case with Doppler-tipped catheters and 
guide wires, and it allows assessment of left ventricular mass, 
end-diastolic volume, systolic function, myocardial infarction 
and ischemia. In the present study, left anterior descending 
coronary artery stenosis severity was the only demcnstrable 
independent predictor of coronary flow reserve. Although 
myocardial infarction within and ischemia remote to the !eft 
anterior descending coronary stenosis were more common in 
patients with ~70% left anterior descending coronary stenosis, 
these variables were not independently predictive of coronary 
flow reserve in the present study. 
Comparison with previous studies. Iliceto et al. (8) :vere 
the first to demonstrate the feasibility of Doppler iransesoph- 
ageal echocardiography in the assessment of coronary flow 
reserve. II? that srudy, dipyridamole was infused to induce 
coronary vasodilation. However, the study group was relatively 
small, and only six patients had left anterior descending 
coronary artery stenosis. The present study extends the results 
of the previous study (8) by demonstrating the feasibility of 
dobutamine as an agent for augmenting coronary flow veloci- 
ties during transesophageal echocardiography. In addition, the 
present study was able to show that the coronary flow reserve 
index as assessed by dobutamine transesophageal echocardi- 
ography was more sensitive for the detection of intermediate 
left anterior descending coronary artery stenosis compared 
with evaluation of regional left ventricular wall motion. 
The mechanisms by which dobutamine and dipyridamole 
augment coronary flow are distinctly different. Dobutamine 
increases myocardial metabolic demand by enhancing contrac- 
tility and increasing heart rate from beta,-receptor stimulation. 
The increased metabolic demand results in a secondary coro- 
nary vasodilation and enhanced coronary blood flow. Dobut- 
amine can have direct effects on coronary vascular tone by 
activation of beta,- and alpha-receptors, but its secondary 
effects mediated through metabolic demand are more pro- 
nounced. Dipyridamole vasodilates coronary vasculature by 
increasing interstitial concentrations of adenosine, a potent 
coronary vasodilator. It remains i 1 be shown whether dobut- 
amine or dipyridamole il; more ideal for assessing coronary 
flow reserve by transesophagcal echocardmgraphy. 
The mean coronary flow reserve index obtained in normal 
subjects in the study of Iiiceto et al. (8) compared with that in 
the pre:;ent study was greater. These findings may relate to 
differences in dipyridamole and dobutamine or perhaps the 
patient groups studied. Siostrzonek et al. (27) Liemonstrated 
the feasibility of Doppler transesophageal echocardiography to 
measure coronary sinus blood floes velocity as a means of 
mcrsuring coronary llow reserve. In that study, the ratio of 
maximal coronary sinus velocity after dipyridamole infusion to 
that zt control was significantly lower in nine patients with 
idiopathic dilated cardiomyopathy compared with eight control 
subjects. It is unknown whether coronary sinus blood flow 
velocity measuremen!s made using Dopplc~ transesophageal 
echocardiography ~/ill be useful for detecting coronary artery 
disease, particularly single-vessel disease. 
Sturdy limitations. Doppler transesophageal echocardiog- 
raphy of the proximal left anterior descending coronary artery 
is not feasible during dobutamine infusion in all patients. 
However, the technique is safer than cardiac catheterization, 
and serial studies are more feasible. Strictly speaking, Doppler 
transesophageal echocardiography measures coronary velocity, 
not flow. It is possible that the results seen in the present study 
may relate to changes in the lumen area of the coronary artery 
during dobutamine infusior.. We cannot exclude the possibility 
that dilation of the proximal left anterior descenaing coronary 
artery may have led to augmented flow with less of an increase 
in velocity by Doppler echocardiography in patients with left 
anterior descending coronary artery disease. 
Doppler velocity obtained using transesopbageal echocar- 
diography has not been validated against an inciependent 
standard. Also, underestimation of velocities in the proximal 
left anterior descending coronary artery occurs when the angle 
of incidence to fIow is excessive. However, the ratio of maximal 
diastolic velocities at peak dobutamine :o those at control 
should not be affected by the angle of incidence. A spectrum of 
left anterior descending coronary artsry stenoses from 15% to 
60% was present in the intermediate group. It cannot be 
determined whether an abnormal coronary flow reserve index 
in this group was a false positive finding or whether the lack of 
a provoked wall motion abnormality was more specisc for a 
hemodynamically significant coronary stenosis. 
Qualitative assessment of coronary angiograms was per- 
formed. Some studies (28) have demonstrated that quantita- 
tive angiographic assessment might improve identification of 
physiologically significant coronary artery stenoses. However, 
other studies (2) have shown shortcomings of quantitative 
angiography. Perhaps intravascular ultrasound will prove to be 
3 better reference standard for predicting the hemodynamic 
significance of coronary stenose$ on the basis of stenosis 
morphology. 
Conclusions. Doppler transesophageal echocardiography 
during dobutamine infusion can be used to assess coronary 
blood Row velocity and coronary blood Row reserve of the !eft 
anterior descending coronary artery. This technique i, inore 
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sensitive for the detection of intermediate left anterior de- 
scending coronary stenosis than the conventional assessment 
of left ventricular wall motion. The ultimate application of this 
technique remains to he determ:ned but shows promise in the 
assessment of left anterior descending coronary artery disease. 
We appreciate the excellent assistance of Erica Camp in the preparation of the 
manuscript. 
References 
I. White W, Wright CB. Dcty DB, et al. Does visual interpretation of the 
coronary arteriogram predict the physiologic importance of a coronary 
stenosis? N Engl J Med 1984;310:819-24. 
2. Katri?sis D, Webb-Peploc M. Limitations of co~on:.ry an;iography: an 
underestimated problem? Clin Cardiol 1991;14:20-4. 
3. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vaso- 
dilator for studies of the coronary circulation in conscious humans. Circula- 
:ion 1986;3:441-51. 
4. Wilson RF, Laughlin DE, Ackell PH. CI al. Trancluminal, subselective 
measurement of coronary artery blood Row velocu;, and vasodilator reserve 
in man. Circulation 1985;72:82-92. 
5. Geltman EM. Henes G. Senneff MJ, Sobs1 BE, Bergann SR. Increased 
myocardial perfusion at rest and diminished perfusion reserve in patients 
with angina and angiographically normal coronary arteries. J Am Coil 
Cardiol 1900;16:586-95. 
6. Yamagishi Y. Miystakc M, Beppu S, et al. Assessment of coronary blood 
flow by transesophageal two-dimensional pulsed Doppler echocardiography. 
Am J Cardiol 1988;62:641-4. 
7. Isaaz K, Bruntz JF, Ethevenot G, Courtalon T. Aliot E. Noninvasive 
assessment of coroncry flow dynamics before and after coronary angioplasty 
using transcsophageal Doppier. Am J Cardiol 1993;72:1238-42. 
8. Iliceto S, Maragngelli V, Memmola C, Rizzon P. Transesophageal Dopp!er 
echocardiography evaluation of coronary blood Row velocity in baseline 
conditions and during dipyridamole-induced coronary vasodilation. Circula- 
tion lY91:83:61-9. 
0. Picano E, Lalianzi F, Masini M, Distance A, L’Abbate A. High dose 
dipyridamole echocardiography test ir. etlort angina pectoris. J Am Coll 
Cardiol 1986:8:848,54. 
IO. Labovitz AJ, Pearson AL‘, Chaitman BM, Byers SL. Mrosek DG. Doppler 
and two-dimensional echocardiographg assessment of left ventricular func- 
tion hcfnrc and :?f!er ictravenous dipyridsmo!? stress testing for dc:c;tion ,f 
coronary artery disease. Am J Cardiol 1988:62:1180-S. 
1 I. Pirelli S. Daniz GB. Massa D. et al. Exercise thallium scintigraptw versus 
high-dose dipyridamole echocardiography testing for detection of ~symp- 
tomatic restenosis in patients with positive exercise teqts after coronary 
angioplasty. Am J Cardiol 1993;71:1(152-6. 
I?. Berthe C, Pierard LA, Hiemaux M, et al. Predicting the extent and location 
of coronary artery disease in acute myocardial infarction by echocardiogra- 
phy during dobutamine in&ton. Am J Cardirl 1986;58:1167-72. 
13. Mannermg U, Cripps T. Leech G, et al. The dobutamme stress test as an 
alternative to exercise testing after acute mlocardir.: infan,tion. Br Heart J 
1988;59:521-6. 
14. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of 
coronary artery disease during dobutamine infusion. Ci;&aiion 1991;83: 
1605-14. 
15. Lambert H, I&is A, Trumper H, Hanr..th P. Sinlucta,,ious transesophageal 
atrial pacing artd transtisophageal i+vo-dimensional echocardiography: a new 
method of stress echocardiqriphy. J Am Coil Cardiol 1990;16:1143-53. 
16. Agati L Renzl M, Sciomer S, et al. Transesophageal dipyridamole erkr??+ 
diography fo: diagnosis of coronary artery disease. J Am Co11 Cardiol 
1992;19:765-70. 
17. Stoddard MF. Liddell NE, Vogel RI., Lonpaker ?Iz, S&ins I%. Compar- 
ison of cardiac dimensions by ::~~>sesoohageai and transthoracic echocardi- 
ography. Am E;an J 1992:124:67X%’ 
18. Uevereur RB, Alonso DR. Lutas EM. et al. Echocardiographic assessment 
of left veniricular hypertrophy: comparison to necropsy findings. Am J 
Cardiol 1986;57:450-8. 
19. Milliken GA, Johnson DE: Analysis of messy data. In: Milliken GA, Johnson 
DE, editors. Designed Experiments, Vol 1. New York: Van Nostrand 
Reinhold, 1984:33. 
20. Marcus ML, Wilson RF, White CW. Methodsof measurement of myocardial 
blood flow in patients: a critical review. Circulation 1987;2:245-53. 
21. Pichard AD. Gorlin R, Smith H, Ambrose J, Meller J. Coronary flow studies 
in patients with left ventricular hypertrophy of the hypertensive type. Am J 
Cardiol 1981:47:547-54. 
22. McGuinn AL. White CW. Wilson RF. Interstudy variability of coronary flow 
reserve. Influence of heart rate, arterial pressure, and ventricular preload. 
Circulation 1990$1:1319-30. 
23. Clearj RM, Ayor: D. Moore NB, DeBoe SF, Mancini GBJ. Tachycardia, 
contractility and voh.mc loading alter conventional indexes of coronary flow 
reserve, but not the instantaneous hyperemic flow versus pressure slope 
index. J Am Coll Cardiol 1992;20:1261-9. 
24. Uren NG, Marraccini P, Gistri R, DeSilva R. Camici PG. Altered coronary 
vasodilator reserve and metabolism in myocardium subtended by normal 
arteries in pat&s with coronary artery disease. J Am Coil Cardiol 1993;22: 
650-8. 
25. Hoffman JI. Maximal coronary flow and the concept of coronary vascular 
reserve. Circulation 1984;70:153-9. 
26. Klocke FJ. Measurements of corona? Row reserve: defining pathophysiol- 
ogy versus making decisions about patient care. Circulation 1987;76:1183-9. 
27. Siostrzonek P, Kranr A, Hemz G. et al. Noninvasive estimation of coronary 
flow reserve by transesophapal Doppler measurement of coronary sinus 
Row. Am J Cardiol 1993;72:1334-7. 
28. Wilson RF. Marcus ML, White CW. Prediction of the physiologic signifi- 
cance of coronary arterial lesions by quantitative lesion geometry in patients 
with limited coronary artery disease. Circulation i987;75:723-32. 
